Purpose. To describe the antimicrobial resistance profile of Neisseria meningitidis isolates causing invasive disease in Brazil from 2009 to 2016.
INTRODUCTION
Invasive meningococcal disease (IMD) remains a worrying illness because it particularly affects children and healthy young adults, causing severe sequelae or leading to death. Appropriate and rapid antibiotic treatment is of great importance for good outcomes for this disease, as well as chemoprophylaxis, which is given to close contacts to prevent secondary cases.
The empirical treatment of IMD is based on thirdgeneration cephalosporins such as ceftriaxone. Penicillin G remains the antibiotic of choice for treatment of IMD, despite there being reports on the decreased susceptibility of meningococcal isolates to this drug from different countries [1] [2] [3] [4] [5] , including Brazil [6] .
Ceftriaxone, ciprofloxacin and rifampin are currently the recommended antimicrobials for chemoprophylaxis in Brazil [6] . Meningococcal resistance to ciprofloxacin and rifampin has been reported sporadically [7] [8] [9] [10] [11] [12] .
Surveillance of antibiotic resistance is an important issue in the context of infection control, because it enables us to map changes in the antibiotic resistance profile, thus detecting emerging resistance, its geographical distribution and its incidence in terms of patients' age groups, in addition to detecting the association of drug resistance with the characteristics of the pathogens.
In Brazil, the surveillance of meningitis is based on the mandatory notification of all suspected cases to an information system under the coordination of the Ministry of Health. It is recommended that a culture of cerebrospinal fluid and/or blood is performed for every suspected case [6] . All the bacteria isolated from these cases should be referred to one of the laboratories of the National Public Health Laboratory System, for which the Adolfo Lutz Institute (IAL), located in the state of São Paulo, is the national reference laboratory for bacterial meningitis. As part of IMD surveillance, we routinely monitor the susceptibility of meningococcal strains to the most commonly used antibiotics in Brazil for the treatment and chemoprophylaxis.
In the present study, we evaluated the susceptibility of Neisseria meningitidis isolates recovered from IMD cases, collected in all 27 Brazilian states and referred to the IAL from 2009 to 2016, as a continuation of a study carried out from 2006 to 2008 [13] .
METHODS

Bacterial strains
The IAL currently receives an average of 440 meningococcal isolates causing invasive disease per annum from public health laboratories and hospitals from all Brazilian regions for full phenotypic characterization.
Between 2009 and 2016, 16 347 IMD cases were notified to the National Information System for Notifiable Diseases (Sinan), managed by the Brazilian Ministry of Health [14] , of which 4729 (28.9 %) were laboratory-confirmed by culture. Of these 4729 cases, 3548 isolates (75.0 %) were sent to the IAL, of which 2167 (61.2 %) were from the Southeast, 577 (16.2 %) were from the Northeast, 260 (7.3 %) were from the Central-West, 490 (13.8 %) were from the South and 54 (1.5 %) were from the North region of Brazil. The isolates were recovered from normally sterile sites, i.e. cerebrospinal fluid (n=2361; 66.5 %) and blood (n=1187; 33.5 %).
All 3548 IMD isolates were confirmed as N. meningitidis and serogrouped by conventional methods [15] . Serotyping was performed by dot-blotting as previously described [16] . For antimicrobial susceptibility testing a sample (n=2888) was chosen in order to include equivalent percentages of the different meningococcal serogroups received. Therefore, we analysed 611/743 (82.2 %) isolates of serogroup B, 1979/ 2433 (81.3 %) isolates of serogroup C, 187/229 (81.6 %) isolates of serogroup W, 100/130 (77.0 %) isolates of serogroup Y, 7/9 (77.8 %) isolates of serogroup E and 4/4 (100 %) isolates of serogroup X.
Overall, the total sample (n=2888) was represented by serogroups B (n=611, 21.1 %), C (n=1979, 68.5 %), W (n=187, 6.5 %), Y (n=100, 3.5 %), E (n=7, 0.2 %) and X (n=4, 0.1 %). 
Antimicrobial susceptibility testing
Among the 3548 N. meningitidis isolates received, 2888 (81.4 %) were analysed using the broth microdilution method for the determination of minimum inhibitory concentrations (MICs), as recommended by the Clinical and Laboratory Standards Institute (CLSI) (document M7-A10) [17] . The results were interpreted according to the CLSI document M100-S28 [18] . The isolates were tested for ciprofloxacin, chloramphenicol, ceftriaxone, penicillin G, ampicillin and rifampin.
Statistical analyses
Statistical analyses were performed using OpenEpi [19] . The chi-square test with Yate's correction or Fisher's exact test were used. A P value <0.05 was defined as statistically significant.
RESULTS
Antimicrobial susceptibility
The results for the antimicrobial susceptibility testing are summarized in Table 1 . All 2888 tested isolates were ceftriaxone-susceptible, with MICs ranging from 0.0003 to 0.030 µg ml À1 and an MIC 90 of 0.0015 µg ml
À1
. Two (0.07 %) isolates were ciprofloxacin-resistant, showing MICs of 0.125 µg ml À1 and 0.250 µg ml
.
All isolates but one were chloramphenicol-susceptible; the resistant strain presented the phenotype C:4,7:P1.5 and showed an MIC of 8.0 µg ml
Regarding rifampin, the majority of the strains were fully susceptible (MIC 90 =0.250 µg ml
). Two strains (0.07 %), both displaying the phenotype C:23:P1.14-6, showed an MIC of 1.0 µg ml À1 (intermediate), while one strain with the phenotype B:19,7,1:P1.NST and two strains typed as C:23:P1.14-6 presented MICs of !8.0 µg ml À1 (resistant).
A total of 953 (33.0 %) and 1307 (45.3 %) strains presented reduced susceptibility to penicillin G and ampicillin, with MICs 90 of 0.125 and 0.5 µg ml
, respectively.
Although no isolates were resistant to penicillin G in the study period, the results showed an upward trend in MICs for this drug from 2010 (P<0.001) ( Table 2 ).
The correlation between the penicillin G susceptibility results for the 2888 N. meningitidis isolates tested and the strains' characteristics, as well as the patients' demographic data, are shown in Table 3 .
There was no significant difference between the gender and age groups regarding reduced susceptibility to penicillin G; however, we have identified an association between reduced susceptibility to this drug and two Brazilian regions, South and Southeast. With respect to the serogroups, we determined that the serogroup B isolates were less susceptible to penicillin G when compared to the other serogroups (P<0.001). We also determined that the vast majority of serotype 19 isolates inside serogroup B showed intermediate resistance to penicillin G. (P<0.001) ( Table 4) .
DISCUSSION
The present study analysed the results from the antimicrobial resistance laboratory surveillance of IMD isolates from 2009 to 2016 in Brazil, as a continuation of the previous study analysing the period from 2006 to 2008 [13] . Penicillin resistance caused by plasmid-mediated b-lactamase production is rarely detected in N. meningitidis [24] . Alterations in the penA gene have been related directly to reduced susceptibility to penicillin G in these strains [2] and, although resistance to this drug in N. meningitidis is still uncommon, Australia and Italy have very recently reported fully penicillin-resistant isolates according to the CLSI criteria (>0.5 µg ml À1 ) [25, 26] .
Penicillin-resistant N. meningitidis isolates linked to a clonal expansion of serogroup W ST-11 showing the penA_253 allele were reported in Western Australia [27] . In the present study, penicillin-resistant strains were not isolated, but the MIC 50 to penicillin G (0.06 µg ml À1 ) was higher than the one that had previously been found (0.03 µg ml À1 ), showing a trend for increasing MICs to this drug close to the intermediate category [13] .
The results of this study differed from those of our previous study (2006) (2007) (2008) , when there was no significant association between penicillin G-intermediate isolates and any of the studied variables regarding patients' characteristics, Brazilian geographical regions and meningococcal serogroups [13] . In this study we found that the Southeast and South geographical regions were associated with reduced penicillin G susceptibility. Therefore, the distribution of the isolates correlated with the population and income of the different Brazilian regions. The Southeast and South, which are the most populated and highest-income settings, referred most of the isolates to our reference laboratory (n=2157; 74.7 %), whereas the North ranked last in N. meningitidis isolate referral (n=44; 1.5 %), which matches the fact that it has the lowest population density and income.
Brazil is a country with important variations in regional development, including the quality of the disease surveillance health system, as well as disease burden, which is influenced by population density and the presence of urban clusters [28] . Because the South and Southeast are the most populous regions, it is likely that the indiscriminate use of antibiotics is greater in these settings, which favours selective pressure and the appearance of antibiotic-resistant bacteria. The more often antibiotics are used, the more they will promote bacterial resistance. Thus, the significant increase in the number of penicillin G-intermediate N. meningitidis strains seen in Brazil from 2010 may have reflected these regional characteristics.
According to Boeckel et al. [29] , there has been an increase in antibiotic consumption in developing countries, and the highest rates were shown in the BRICS countries (Brazil, Russia, India, China and South Africa) and in French West Africa between 2000 and 2010. As of 2010, in Brazil, some measures have been taken by the National Agency of Sanitary Surveillance (ANVISA) [30] to control the sale of antibiotics; it is now more difficult to buy these drugs and doctors should be more careful in prescribing them. The results of these recommendations may be reflected in the mid-term recovery of pathogen sensitivity to antimicrobials, as seen in a study carried out in Zamora, Spain, in which the recovery of the sensitivity of respiratory pathogens was related to a reduction in the use of antimicrobials [31] .
Reduced penicillin G susceptibility has been associated with different serogroups. In our study, we found that serogroup B was associated with this resistance profile. The data from an active population-based surveillance system conducted in the United States showed a strong association between increased MICs to penicillin G and serogroup Y when compared to the other serogroups combined [5] . In Ontario, Canada, reduced susceptibility to this drug was not only associated with serogrup Y, but also with serogroup W in the 2000s [3] . A previous study carried out in Spain also reported a higher prevalence of reduced penicillin G susceptibility in serogroup C, when compared to other serogroups [32] .
A change in the epidemiological scenario could be caused by the emergence of a particular clone. A meningococcal serogroup shift was observed in Europe with the increase of N. meningitidis C that was associated with the emergence of serotype 2b (C:2b) and with reduced penicillin G susceptibility, especially in Spain, England (United Kingdom) and Wales (United Kingdom) [33, 34] . The association of other specific serogroups:serotypes with reduced penicillin G susceptibility, such as serotype 1 with serogroup B, has also been observed [35] .
In Brazil, serogroup B was the most frequently isolated serogroup until 2001. From 2002, serogroup C became the most prevalent serogroup. The hypervirulent lineage ST-103 clonal complex has been the most frequent genotype in this serogroup. The increased incidence of IMD involving serogroup C led to the introduction of routine meningococcal C conjugate (MCC) vaccination in Brazil in 2010. A study of the impact of MCC vaccination after 4 years of its implementation found a reduction in MenC rates among vaccinated targeted age groups [36] . As a booster dose among the adolescent population was not adopted until 2017, N. meningitidis C still circulates as the prevalent serogroup in Brazil. Nevertheless, we have identified a significant association between reduced penicillin G susceptibility and serogroup B. There was also an association of serotype 19 within serogroup B with this type of resistance and, in light of our knowledge, this has not yet been reported. Although there is no evidence that there has been a clonal expansion of B:19 that is associated with reduced penicillin susceptibility, this clone has to be closely monitored to fully understand its impact in the future.
Although meningococcal resistance to ciprofloxacin remains uncommon, strains that are not susceptible (intermediate or resistant) to this drug have been reported occasionally in the Americas and Europe [37] . During the study period, the emergence of resistance to ciprofloxacin was detected in two N. meningitidis isolates from 2012 and 2013 belonging to ST-103 and ST-11 complexes, two important hypervirulent clones circulating in Brazil. Both strains presented a threonine (Thr) fi isoleucine (Ile) mutation at amino acid 91 located in the QRDR of the gyrA gene, the main mechanism of ciprofloxacin resistance in meningococci [37] .
N. meningitidis remains extremely susceptible to thirdgeneration cephalosporins (C3Gs), showing low MICs, as presented by our strain collection (MIC 90 =0.0015 µg ml
À1
). However, a study recently conducted in France detected that 2 % of all invasive meningococcal isolates from 2012 to 2015 presented reduced susceptibility to C3Gs (MIC 90 =0.125 µg ml À1 ) [38] . All isolates harboured a new penA_327 allele, which is related to reduced susceptibility to C3Gs and was previously described in Neisseria gonorrhoeae [38, 39] . These recent data alert us to the need for the reinforcement of antimicrobial surveillance, as well as rational use of C3G in the treatment of IMD.
Resistance to chloramphenicol, which can be used as an alternative treatment in cases of penicillin allergy [40] , was minimal in our study, with only one resistant strain being detected, in 2009. Rifampin resistance was also sporadic in the period that was analysed. Similar data were previously reported in different countries [13, 36, 41] .
Conclusion
The antibiotics currently recommended for the treatment and chemoprophylaxis of IMD in Brazil remain adequate and effective agents; however, the continued surveillance of N. meningitidis antimicrobial susceptibility profiles is important in order to monitor changes in antibiotic resistance either geographically, over time or in association with emergent clones.
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